This article focuses on syringe fill-finish challenges pharmaceutical companies are experiencing with complex biologics, including drug stability, plunger placement techniques, syringe and plunger formats. It explains the need for a highly accurate, precise, and repeatable syringe filling process.
In a 2018 interview, Esteban Santos, executive VP for operations at Amgen, described how pharmaceutical companies need to accelerate drug development, build facilities faster and respond faster to changing market conditions. This blog will explore how Vanrx’s aseptic processing machines can help achieve these goals.
Vanrx was featured in the leading international publication Cleanroom Technology for redesigning the aseptic filling process with our gloveless isolator technology. This article explains how the future of aseptic filling is shifting away from glove ports / conventional isolators and moving toward robotic systems.
Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.
If press-fit closures were the current standard for sealing pharmaceutical vials, would pharmaceutical companies switch to aluminum crimp caps? Driven by data, pharma companies would not make the switch. This blog reviews the benefits of plastic closures in replacing aluminum crimp caps.
How do pharmaceutical manufacturing facilities modernize their fill-finish operations? How can the industry innovate to solve a chronic drug shortage problem? These were the BIG questions asked when Vanrx recently participated in articles with BioPharm International and Pharmaceutical Technology.